FDA Approved: ITRACONAZOLE — Supplemental Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for itraconazole from Alembic Pharmaceuticals Inc., resulting in a label-related approval update for this antifungal.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspergillosis
• Blastomycosis
• Coccidioidomycosis
• Histoplasmosis
• Onychomycosis
• Sporotrichosis

Drugs mentioned

• Itraconazole (Itraconazole)

Snippet

SUPPL AP for ITRACONAZOLE (ITRACONAZOLE)